It seems chronic stress has a fringe benefit: It protects women from breast cancer. A recent prospective cohort study of almost 7,000 women participating in the Copenhagen City heart study finds that women with self-perceived high levels of stress have a 40% lower risk of first-time primary breast cancer than less stressed counterparts.
It seems chronic stress has a fringe benefit: It protects women from breast cancer. A recent prospective cohort study of almost 7,000 women participating in the Copenhagen City heart study finds that women with self-perceived high levels of stress have a 40% lower risk of first-time primary breast cancer than less stressed counterparts.
During 12 years of follow-up, 251 women in the study were diagnosed with breast cancer. Compared with women with low stress levels, those who were highly stressed had a hazard ratio of 0.60 (95% CI; 0.37–0.97) for breast cancer. In addition, each increase in stress level on a 6-point stress scale was associated with an 8% lower risk of primary breast cancer (hazard ratio [HR] 0.92; 0.85–0.99).
The researchers surmise the connection is based on the ability of chronic stress to impair estrogen synthesis, and high endogenous concentrations of estrogen are a known risk factor for breast cancer. The authors of the study caution, however, that the cumulative health effects of ongoing, intense stress may outweigh the protection offered against breast cancer.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More